The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves early initiation of HIV therapy in pregnant patients with newly identified HIV infection.
Pregnancy
Presentation to the ED or obstetrical triage during the index pregnancy.
No established prenatal care (≤1 visit) and/or no documented HIV or syphilis testing during the current pregnancy.
Medically unstable or critically ill at the time of ED presentation.
Incarcerated at the time of ED presentation.
Decline participation in testing (opt-out) or refuse survey participation.
The University of Texas Health Science Center, Houston
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator